128 related articles for article (PubMed ID: 4211730)
1. [Use of citrate nicamétate at high doses in cardiovascular surgery].
Stankowiak C; Vandecasteele J; Soots G
Lille Med; 1973 Nov; 18(9):1039-42. PubMed ID: 4211730
[No Abstract] [Full Text] [Related]
2. [Clinical experiences with a new vasodilator: 3-(methylhydroxyethylamino)-2-hydroxypropyltheophylline nicotinate].
Sideri GC; Fumagalli G; Locatelli R
Arch Patol Clin Med; 1965 Jun; 41(6):479-83. PubMed ID: 5319767
[No Abstract] [Full Text] [Related]
3. [Compensation grade of arterial occlusions and action of intravenously administered vasoactive drugs].
Bollinger A; Lüthy E
Helv Med Acta Suppl; 1967 May; 47():128. PubMed ID: 5286297
[No Abstract] [Full Text] [Related]
4. [Therapeutic effects of slow acting nicotinyl alcohol in vascular diseases].
Chiti E
Clin Ter; 1965 Oct; 35(1):38-53. PubMed ID: 5860388
[No Abstract] [Full Text] [Related]
5. The action of tetranicotinoylfructose in peripheral vascular disease.
Andrews G; Judge TG; Walkey F
Practitioner; 1973 Jul; 211(261):83-5. PubMed ID: 4580277
[No Abstract] [Full Text] [Related]
6. [Vasodilator treatment in sudden deafness].
Blaettler WH
Rev Med Suisse Romande; 1973 Oct; 93(10):753-6. PubMed ID: 4757065
[No Abstract] [Full Text] [Related]
7. [Experience with Complamin in peripheral circulation disorders].
Wittenburg H
Med Monatsschr; 1969 Dec; 23(12):558-61. PubMed ID: 5387170
[No Abstract] [Full Text] [Related]
8. [Testing of arthro-menthoneurine gel in 100 cases of a medical practice].
Gorka G
Med Welt; 1979 Aug; 30(33):1202-3. PubMed ID: 386024
[No Abstract] [Full Text] [Related]
9. [Therapeutic experiences with an adenosine-theophylline Sodium-nicotinate combination in peripheral circulation disorders].
Weber G; Vogel A
Dermatol Wochenschr; 1967 Nov; 153(46):1278-82. PubMed ID: 5588908
[No Abstract] [Full Text] [Related]
10. [Effect of vasodilator agents on oral glucose tolerance and serum insulin in intravenous long-term treatment of blood circulation disorders involving peripheral arteries].
Heidrich H; Schirop T
Verh Dtsch Ges Inn Med; 1975; 81():1496-7. PubMed ID: 818839
[No Abstract] [Full Text] [Related]
11. [Complamine in obliterating peripheral circulatory disorders].
Kusztos D; Bereczky M; Fono J
Med Monatsschr; 1970 Mar; 24(3):127-8. PubMed ID: 5436974
[No Abstract] [Full Text] [Related]
12. [Clinical trial of Nicametate in vascular pathology].
Langeron P
J Sci Med Lille; 1972 Apr; 90(4):179-82. PubMed ID: 5079565
[No Abstract] [Full Text] [Related]
13. [Clinical studies and therapeutic trials with a new phlebotropic substance].
Matanic V
Z Allgemeinmed; 1970 Apr; 46(10):530-4. PubMed ID: 4945230
[No Abstract] [Full Text] [Related]
14. Inositol hexaniacinate.
Altern Med Rev; 1998 Jun; 3(3):222-3. PubMed ID: 9630739
[No Abstract] [Full Text] [Related]
15. [Effect on the eye vessels of vasodilator agents after their administration by different electrophoretic methods (clinical study)].
Nurieva SM
Vestn Oftalmol; 1978; (2):71-3. PubMed ID: 349832
[No Abstract] [Full Text] [Related]
16. Tetranicotinoylfructose in disorders of digital blood flow.
Holti G; Newell DJ; Poole HG
Practitioner; 1971 Nov; 207(241):654-8. PubMed ID: 4944129
[No Abstract] [Full Text] [Related]
17. The effects of xanthinol nicotinate on the small blood vessels.
Davis E; Rozov H
Bibl Anat; 1973; 11():334-9. PubMed ID: 4789059
[No Abstract] [Full Text] [Related]
18. [Therapeutic possibilities in blood circulatory and lipid metabolism disorders].
Schneider H
Z Allgemeinmed; 1971 Dec; 47(36):1916-8. PubMed ID: 5003958
[No Abstract] [Full Text] [Related]
19. [Cardilan in the treatment of obliterative diseases of peripheral arteries].
Ginko T; Adamczyk R; Dyaczyńska A
Wiad Lek; 1971 Jun; 24(12):1211-5. PubMed ID: 5561279
[No Abstract] [Full Text] [Related]
20. Vasodilator drugs and peripheral vascular disease.
Drug Ther Bull; 1972 Nov; 10(23):91-2. PubMed ID: 4144248
[No Abstract] [Full Text] [Related]
[Next] [New Search]
